Effects of Non-Invasive Vagus Nerve Stimulation in Adolescent Burn Patients
The Effects of Non-Invasive Vagus Nerve Stimulation on Anxiety, Sleep Quality, Pain, Itching, and Autonomic Functions in Burn Patients Aged 12-18
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will evaluate the effects of non-invasive vagus nerve stimulation in adolescents aged 12 to 18 years who have burn injuries. The study will include patients who have completed the acute phase after burn injury and who have symptoms such as anxiety, sleep problems, pain, or itching. Participants will be randomly assigned to one of two groups. One group will receive conventional physiotherapy together with non-invasive vagus nerve stimulation. The other group will receive only conventional physiotherapy. The treatment program will be applied 5 days per week for a total of 10 sessions. The study will assess whether non-invasive vagus nerve stimulation improves anxiety, sleep quality, pain, itching, and autonomic nervous system function. These outcomes will be measured before and after the treatment program using clinical scales and heart rate variability measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
May 5, 2026
April 1, 2026
4 months
April 28, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in anxiety level
Anxiety level will be assessed using the Beck Anxiety Inventory. The scale consists of 21 items scored from 0 to 3, with a total score ranging from 0 to 63. Higher scores indicate higher anxiety severity.
Baseline and after completion of the 10-session treatment program, approximately 2 weeks
Change in sleep-related symptoms
Sleep-related symptoms will be assessed using the Adolescent Insomnia Scale. The scale includes 13 items and evaluates sleep onset, sleep maintenance, and sleep dissatisfaction/disturbances. Total scores range from 0 to 52, with higher scores indicating more severe insomnia symptoms.
Baseline and after completion of the 10-session treatment program, approximately 2 weeks
Change in pain intensity
Pain intensity will be assessed using the Visual Analog Scale. Participants will mark their pain level on a 100-mm line, where higher scores indicate greater pain intensity.
Baseline and after completion of the 10-session treatment program, approximately 2 weeks
Change in pruritus severity
Pruritus severity will be assessed using the 12-Item Pruritus Severity Scale. The scale evaluates the severity, frequency, duration, distribution, and impact of itching on daily life and sleep. Higher scores indicate more severe pruritus.
Baseline and after completion of the 10-session treatment program, approximately 2 weeks
Change in heart rate variability parameters
Autonomic nervous system function will be assessed using heart rate variability measurements recorded with a Polar H10 heart rate sensor. RR interval data will be analyzed using Kubios HRV software. Time-domain, frequency-domain, and non-linear heart rate variability parameters will be evaluated.
Baseline and after completion of the 10-session treatment program, approximately 2 weeks
Study Arms (2)
Non-Invasive Vagus Nerve Stimulation Plus Conventional Physiotherapy
EXPERIMENTALParticipants in this group will receive non-invasive vagus nerve stimulation in addition to conventional physiotherapy. The treatment will be applied 5 days per week for a total of 10 sessions.
Conventional Physiotherapy
ACTIVE COMPARATORParticipants in this group will receive conventional physiotherapy only. The treatment will be applied 5 days per week for a total of 10 sessions.
Interventions
Non-invasive vagus nerve stimulation will be applied using electrodes placed on the tragus and concha regions of both ears. Stimulation will be delivered with a biphasic asymmetrical waveform, a pulse duration of 300 microseconds, and a frequency of 25 Hz for 20 minutes. The stimulation intensity will be gradually increased in 0.1 mA steps until the participant's sensory threshold is reached. The intervention will be applied 5 days per week for a total of 10 sessions.
Participants will receive an individualized conventional physiotherapy program based on their clinical needs. The program may include strengthening exercises, stretching exercises, balance exercises, active and passive range-of-motion exercises, and interventions for edema management. Each session will last approximately 45 minutes and will be applied 5 days per week for a total of 10 sessions.
Eligibility Criteria
You may qualify if:
- Being between 12 and 18 years of age
- Having completed the acute phase after burn injury, with at least 1 month and at most 1 year since the burn injury
- Having second- or third-degree burns involving 5% to 30% of total body surface area
- Having at least one of the following complaints: anxiety, poor sleep quality, pain, or itching
- Written informed consent provided by the parent or legal guardian, and willingness of the participant to take part in the study
- Ability to read and understand Turkish
You may not qualify if:
- Infection, ulcer, or scar tissue on the auricle
- Burn injury in the head and neck region that prevents application of the device to the auricular vagus nerve area
- Metallic implant in the skull, excessive sensitivity in the ear, ear injury, or ear inflammation
- Chronic pulmonary and/or cardiac disease
- Heart rate below 60 beats per minute
- Presence of a pacemaker, cochlear implant, or similar implanted device
- Uncontrolled hypertension
- Lack of cooperation
- Refusal or inability of the parent or legal guardian to sign the informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kartal Dr. Lütfi Kırdar City Hospital Burn Unit
Istanbul, Kartal, 34865, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sümeyye Akçay, Asst. Prof.
Fenerbahçe University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessor will be blinded to group allocation. Participants will be evaluated before and after the intervention by an assessor who will not be involved in treatment allocation or intervention delivery.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
April 28, 2026
First Posted
May 5, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to the involvement of pediatric participants and the sensitive nature of clinical and health-related data. Study results may be reported in aggregate form in scientific presentations or publications, without identifying individual participants.